IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News:
MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, today issued its business update for the third quarter and for the nine months ended September 30, 2011.
